BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36700397)

  • 21. EPAS1-related pheochromocytoma/paraganglioma.
    Alzahrani AS; Alswailem M; Buffet A; Alghamdi B; Alobaid L; Alsagheir O; Al-Hindi H; Pacak K
    Endocr Relat Cancer; 2024 Aug; 31(8):. PubMed ID: 38767322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variability of hypoxia-inducible factor alpha (HIFA) genes in familial erythrocytosis: Analysis of the literature and genome databases.
    Kristan A; Debeljak N; Kunej T
    Eur J Haematol; 2019 Oct; 103(4):287-299. PubMed ID: 31376207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
    Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
    Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
    Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
    Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EPAS1 p.M535T mutation in a Bulgarian family with congenital erythrocytosis.
    Alaikov T; Ivanova M; Shivarov V
    Hematology; 2016 Dec; 21(10):619-622. PubMed ID: 27292716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial erythrocytosis arising from a gain-of-function mutation in the HIF2A gene of the oxygen sensing pathway.
    Percy MJ
    Ulster Med J; 2008 May; 77(2):86-8. PubMed ID: 18711622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chiari Malformation Type 1 in
    Rosenblum JS; Maggio D; Pang Y; Nazari MA; Gonzales MK; Lechan RM; Smirniotopoulos JG; Zhuang Z; Pacak K; Heiss JD
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
    Lappin TR; Lee FS
    Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of genetic variants in the
    Delamare M; Le Roy A; Pacault M; Schmitt L; Garrec C; Maaziz N; Myllykoski M; Rimbert A; Karaghiannis V; Aral B; Catherwood M; Airaud F; Mansour-Hendili L; Hoogewijs D; Peroni E; Idriss S; Lesieur V; Caillaud A; Si-Tayeb K; Chariau C; Gaignerie A; Rab M; Haferlach T; Meggendorfer M; Bézieau S; Benetti A; Casadevall N; Hirsch P; Rose C; Wemeau M; Galacteros F; Cassinat B; Bellosillo B; Bento C; Van Wijk R; Petrides PE; Randi ML; McMullin MF; Koivunen P; Girodon F; Gardie B;
    Haematologica; 2023 Nov; 108(11):3068-3085. PubMed ID: 37317877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis.
    Martini M; Teofili L; Cenci T; Giona F; Torti L; Rea M; Foà R; Leone G; Larocca LM
    Haematologica; 2008 Jul; 93(7):1068-71. PubMed ID: 18508787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
    Yang C; Zhuang Z; Fliedner SM; Shankavaram U; Sun MG; Bullova P; Zhu R; Elkahloun AG; Kourlas PJ; Merino M; Kebebew E; Pacak K
    J Mol Med (Berl); 2015 Jan; 93(1):93-104. PubMed ID: 25263965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary gene mutations in Korean patients with isolated erythrocytosis.
    Jang JH; Seo JY; Jang J; Jung CW; Lee KO; Kim SH; Kim HJ
    Ann Hematol; 2014 Jun; 93(6):931-5. PubMed ID: 24482100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIF pathway mutations and erythrocytosis.
    McMullin MF
    Expert Rev Hematol; 2010 Feb; 3(1):93-101. PubMed ID: 21082936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental vascular malformations in EPAS1 gain-of-function syndrome.
    Rosenblum JS; Wang H; Dmitriev PM; Cappadona AJ; Mastorakos P; Xu C; Jha A; Edwards N; Donahue DR; Munasinghe J; Nazari MA; Knutsen RH; Rosenblum BR; Smirniotopoulos JG; Pappo A; Spetzler RF; Vortmeyer A; Gilbert MR; McGavern DB; Chew E; Kozel BA; Heiss JD; Zhuang Z; Pacak K
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation Syndrome.
    Dmitriev PM; Wang H; Rosenblum JS; Prodanov T; Cui J; Pappo AS; Gilbert MR; Lutty GA; Chan CC; Chew EY; Pacak K; Zhuang Z
    JAMA Ophthalmol; 2020 Feb; 138(2):148-155. PubMed ID: 31876943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
    Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
    Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).
    Bento C; Almeida H; Maia TM; Relvas L; Oliveira AC; Rossi C; Girodon F; Fernandez-Lago C; Aguado-Diaz A; Fraga C; Costa RM; Araújo AL; Silva J; Vitória H; Miguel N; Silveira MP; Martin-Nuñez G; Ribeiro ML
    Eur J Haematol; 2013 Oct; 91(4):361-8. PubMed ID: 23859443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital erythrocytosis.
    Mallik N; Das R; Malhotra P; Sharma P
    Eur J Haematol; 2021 Jul; 107(1):29-37. PubMed ID: 33840141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients.
    Chandrasekhar C; Pasupuleti SK; Sarma PVGK
    Blood Cells Mol Dis; 2020 Nov; 85():102479. PubMed ID: 32739800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
    Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
    Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.